As a new foreign trade service provider driven by both technology transformation and foreign trade operations, HiSiaddi has established a "1+2+3+4=1" service system and can supply lithium iodide (LiI) sourced directly from multiple well-known original manufacturers.
As a research-and-development-oriented foreign trade enterprise, unlike single-brand factories that only promote their own products, we objectively analyze multiple high-market-share domestic and international LiI brands and share their major technological process advances and breakthroughs, enabling buyers to access authentic, practical, and up-to-date market intelligence.
If you require more comprehensive and valuable LiI market information, please contact HiSiaddi customer service.
China’s top 5 LiI export manufacturers (by market share): Boyuan Co., Ltd., Ganfeng Lithium, Tianqi Lithium, Guanghua Technology, Xiamen Tungsten Co., Ltd. All specialize in battery/pharmaceutical-grade anhydrous lithium iodide exports.
1. Purity Purification Process Breakthrough: Realized industrial mass production of 99.9999% (6N) electronic-grade anhydrous lithium iodide, with total impurities <1 ppm, residual iodine ≤5 ppm, and moisture ≤6 ppm. This breakthrough broke overseas enterprises’ monopoly over ultra-high-purity LiI mass production, supported by an exclusive self-produced hydroiodic acid production line (only 2 licensed manufacturers in China).
2. Electrolyte Formulation Modification Breakthrough: Self-developed iodide ion doping modification technology boosts ionic conductivity by 1–2 orders of magnitude to 5.57 mS/cm after lithium iodide incorporation into sulfide electrolytes, reducing solid-solid interfacial impedance to below 15 Ω·cm for mass production validation of all-solid-state lithium metal batteries.
3. Production Loss Optimization: Coupled phosphorous acid reduction + closed vacuum crystallization processes cut comprehensive raw material loss from the industry average of 22% to 8.7%, lowering mass production costs by 18% versus sector benchmarks.
1. Thermal Stability Indicator Improvement: Product thermal decomposition rate reaches only 0.37% after 2 hours at 180°C, a 42% reduction from the industry average of 0.64%, satisfying high-temperature operating requirements for solid-state batteries paired with high-nickel positive electrodes.
2. Automated Quality Control Technical Renovation Completed: A new 3,000-ton/year dedicated production line in Xinyu integrates real-time online ICP-MS impurity monitoring systems + minus 48°C nitrogen-sealed drying and packaging, stabilizing product moisture below 8 ppm and narrowing batch fluctuation range from ±7 ppm to ±1.5 ppm to meet automotive-grade AEC-Q200 certification standards.
3. Raw Material Supply Chain Optimization: Direct lithium carbonate supply from salt lake lithium extraction production lines reduced lithium raw material procurement costs by 14%, driving a simultaneous 7%–9% reduction in FOB export quotations.
1. Halogen Impurity Control Breakthrough: Residual free iodine ≤8 ppm and heavy metal impurities ≤0.1 ppb, meeting Toyota-Panasonic sulfide all-solid-state battery raw material access limits (industry general standard ranges 15–25 ppm). Bulk sample procurement trials with Japanese battery manufacturers launched in 2026.
2. Anhydrous Dehydration Process Optimization: Multi-stage gradient vacuum drying technology implemented, stabilizing finished product moisture at 10–12 ppm, a notable improvement over the previous generation’s 15–18 ppm moisture range to reduce battery gas generation and failure risks.
1. Synthetic Route Patent Breakthrough (Patent Granted March 2026): Carbon dioxide atmosphere + quaternary ammonium salt ion exchange wet new process achieves in-situ removal of sulfate, calcium, and magnesium impurities from lithium feedstock, producing ≥99.95% anhydrous lithium iodide without secondary recrystallization. Eliminating traditional refining procedures cuts per-ton energy consumption by 23%.
2. Lithium Iodide Trihydrate Conversion Improvement: Optimized intermediate low-temperature decomposition technology raises lithium iodide trihydrate to anhydrous conversion rate from 89% to 97.2%, cutting waste byproduct discharge by 65% to comply with EU REACH environmental import regulations.
1. Precise Particle Morphology Optimization: Mass-produced crystal directional regulation technology delivers flaky lithium iodide with D50 precisely controlled at 8.3 μm, raising tap density to 2.15 g/cm³ (industry average: 1.75 g/cm³). Cold pressing forming yield for solid electrolyte film manufacturing rises by 12%, reducing scrapping losses from broken electrolyte films.
2. Pharmaceutical-Grade Refining Upgrade: Iterated heavy metal removal technology for pharmaceutical lithium iodide complies with U.S. FDA API impurity standards, shortening North American customs clearance cycles for medical lithium-iodine battery raw material exports by 40%.
Global Top 5 Overseas LiI Manufacturers: Albemarle (USA), American Elements (USA), Leverton Lithium (UK), Merck (Germany), TCI (Japan). Combined global lithium iodide market share: approximately 49.8%.
1. Dehydration Process Breakthrough: Closed-loop deep cold vacuum drying technology delivers high-end anhydrous lithium iodide with moisture ≤10 ppb (0.001%), currently the world’s optimal moisture control standard, designated as fixed raw material supply for Tesla semi-solid power batteries.
2. Cycle Performance Modification Optimization: New lattice-doped modified lithium iodide formulations extend lithium metal battery cycle life from 820 cycles to over 1,180 cycles, with long-term fixed supply contracts signed with leading North American lithium battery enterprises starting in 2026.
3. Low-Carbon Production Improvement: Supporting iodide byproduct recovery systems cut production carbon emissions by 27% versus 2024 levels, complying with EU carbon border adjustment mechanism import standards.
1. Single-Crystal High-Purity Synthesis Breakthrough: Pilot-scale mass production of laboratory single-crystal growth technology realized, delivering 99.99995% ultra-high-purity lithium iodide with total impurities <0.5 ppb, suitable for infrared optical components and medical implant lithium-iodine pacemaker battery raw materials. Semiconductor-sector export volume rose 25% year-on-year.
2. Repackaging Moisture-Proof Technical Renovation: In-situ inert gas vacuum packaging technology reduces moisture absorption rate by 83% after air exposure upon opening, drastically cutting storage loss for overseas clients.
1. Resource-Side Cost Reduction Breakthrough: Acquisition of Chilean iodine mines paired with self-produced hydroiodic acid cuts overall raw material costs by 12%, enabling an 8% reduction in European offshore pricing and lowering procurement costs for European pharmaceutical buyers.
2. Environmental Process Improvement: Waste-free neutralization synthetic routes achieve full recovery and regeneration of production waste liquid into hydroiodic acid, satisfying European EHS import environmental audits and lowering customs sampling failure rates from 11% to 1.2%.
1. Ultra-Fine Powder Process Breakthrough: Jet milling coupled with low-temperature crystallization produces nano-scale lithium iodide with D50 ≤300 nm, suitable for laboratory solid-state electrolyte R&D and quantum optical material preparation, raising delivery stability of customized research materials by 90%.
2. Trace Customization Improvement: Upgraded inert sealed packaging for small-pack high-purity lithium iodide extends shelf life of single-gram reagent products from 18 months to 36 months, reducing raw material scrapping rates for end research clients.
1. Pharmaceutical Impurity Control Breakthrough: Targeted arsenic and lead hazardous element removal processes implemented, enabling lithium iodide compliance with both JP18 and USP pharmacopoeia standards. Medical lithium-iodine battery raw materials entered Japanese and Southeast Asian medical device supply chains, driving volume growth in pharmaceutical import procurement.
2. Lithium Iodide Trihydrate Stability Improvement: Optimized formulation with coordinating stabilizers delivers lithium iodide trihydrate resistant to deliquescence and caking after 6 months ambient storage, eliminating pre-treatment steps for downstream pharmaceutical feeding processes.
1. Procurement Cost Advantages: New domestic leading-brand production processes drive mass production cost reductions, lowering FOB average prices for equivalent-grade lithium iodide by 6%–11% compared to 2024 levels. Integrated technical renovations by overseas top manufacturers reduced European and American local quotations by 7%–9%, delivering significant overall procurement cost compression.
2. Supply Chain Stability Advantages: Domestic mass production of 6N ultra-high-purity lithium iodide broke overseas premium pricing monopolies, enabling overseas buyers to establish dual domestic and foreign supplier backup systems to mitigate risks of single overseas brand supply disruptions and price hikes. Domestic products have successively obtained FDA, REACH, and AEC-Q200 certifications, boosting European, American, and Japanese customs clearance efficiency by over 30%.
3. Inventory Loss Advantages: Industry-wide upgrades to moisture control and moisture-proof packaging technology lowered lithium iodide storage moisture-induced scrapping rates from 12%–18% to below 3%, drastically cutting inventory depreciation costs for clients.
1. Power Battery End Products: High-purity modified lithium iodide cuts fast-charging time to 80% state of charge within 15 minutes, raises cell cycle life by 30%–45%, extends new energy vehicle power battery service life, and reduces vehicle warranty costs. Solid-state battery energy density rises by 18%, delivering synchronous improvements to vehicle driving range.
2. Medical End Products (Cardiac Pacemakers, Implantable Lithium-Iodine Batteries): Ultra-high-purity pharmaceutical lithium iodide drastically reduces impurity levels, lowering leakage and failure fault rates of implantable batteries by 62%. Service life of end medical devices extends from 8 years to 12–15 years, enhancing competitiveness of medical device finished products.
3. Energy Storage & Optical End Products: Optimized ultra-fine particle size and high-stability lithium iodide improve stability of optical sensors and industrial energy storage electrolytes, cutting low-temperature attenuation rates of energy storage equipment by 25% and boosting yield rates of optical components by over 10%.
For more comprehensive and valuable LiI market information, please contact HiSiaddi customer service.